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Factors associated with increased mortality and 
prolonged length of stay in an adult intensive 
care unit 
Fatores associados à maior mortalidade e tempo de internação 
prolongado em uma unidade de terapia intensiva de adultos
INTRODUCTION
The intensive care unit (ICU) is specially dedicated to patients who 
are able to be recovered from severe and/or high risk diseases and require 
continuous medical care, multi-professional health care team, and other 
specialized human resources, in addition to special devices.(1)  Intensive 
care unit  stands for urgency and its mortality rates range between 5.4 
and 33%.(2-5)
According to the 2nd Brazilian ICU Census, the Brazilian ICU average 
stay is between one and six days(6) and in a systematic literature review, Wil-
liams et al.(3) reported an international average of 5.3 ± 2.6 days. However, 
due to continuous technological development, severely ill patients are cur-
rently kept in these units for long periods of time, even when death is not 
avoidable, entailing heavy financial, moral and psychological burdens.(7) 
This study was aimed to identify the factors associated with increased 
mortality and prolonged length of stay in an adult ICU.
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ABSTRACT
Objective: The intensive care unit 
is synonymous of high severity, and its 
mortality rates are between 5.4 and 
33%. With the development of new 
technologies, a patient can be main-
tained for long time in the unit, caus-
ing high costs, psychological and mor-
al for all involved. This study aimed to 
evaluate the risk factors for mortality 
and prolonged length of stay in an 
adult intensive care unit.
Methods: This study included all 
patients consecutively admitted to the 
adult medical/surgical intensive care 
unit of the Hospital das Clínicas of 
Universidade Estadual de Campinas 
in a six-month period. Data such as 
gender, age, diagnosis, medical histo-
ry, APACHE II score, days of invasive 
mechanical ventilation, orotracheal re-
intubation, tracheostomy, hospitaliza-
tion days in the intensive care unit and 
outcome (either discharge or death) 
were collected. 
Results: Four hundred and one 
patients were included in this study of 
which 59.6% were men and 40.4% 
women with mean age of 18.0 ±53.8 
years, the mean intensive care unit stay 
was 8.2±10.8 days and the mortality rate 
was 13.5%. APACHE II>11, tracheos-
tomy and reintubation were significantly 
associated  (p<0.0001) with mortality 
and prolonged intensive care unit stay.
Conclusion: The risk factors 
for increased mortality and pro-
longed intensive care unit stay were: 
APACHE>11, orotracheal reintuba-
tion and tracheostomy. 
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Mortality; Length of stay; Risk factors
Received from the Hospital das Clínicas 
of Universidade Estadual de Campinas – 
UNICAMP – Campinas (SP), Brazil.
Submitted on January 30, 2009.
Accepted on August 5, 2010.
Author for correspondence:
Ana Beatriz Francioso de Oliveira
Centro de Atenção Integral á Saúde da 
Mulher (CAISM – UNICAMP)
Serviço de Fisioterapia
Rua Alexandre Flemming – Cidade 
Universitária
Zip Code: 13083-881 – Campinas (SP), 
Brazil.
Phone: +55 19 35219428 / 35219483
E-mail: anabiafisio@yahoo.com.br
ORIGINAL ARTICLE
Factors associated with increased mortality and prolonged length of stay 251
Rev Bras Ter Intensiva. 2010; 22(3):250-256
METHODS
A prospective study was conducted on the clinical/
surgical adult ICU of the Hospital de Clínicas of Uni-
versidade Estadual de Campinas (HC/UNICAMP) 
which included all patients consecutively admitted to 
the unit in a six-month period. Patients with missing 
data, transferred to other hospitals before discharge 
from the ICU and with unfeasible follow-up due to 
lost data or incorrect records were excluded. 
The patients were characterized by gender, age, di-
agnosis, medical history (including chronic systemic 
arterial hypertension [SAH], diabetes mellitus [DM], 
chronic obstructive pulmonary disease [COPD], 
smoking status, alcoholism, liver failure, renal fail-
ure and cancer) obtained from the patients’ medi-
cal chart within the first 24 hours of admission. The 
Acute Physiology and Chronic Health Evaluation II 
(APACHE II) score was used to determine the prima-
ry disease’s severity. All clinical and laboratory data for 
the score calculation were part of the patient’s routine 
care. Other daily collected information were: invasive 
mechanical ventilation (IMV) days, orotracheal rein-
tubation (ReOTI), tracheostomy, ICU length of stay 
and ICU outcome (discharge/death).
The IMV time was considered as the period elapsed 
from orotracheal intubation (OTI) to successful ex-
tubation provided that the patient remained at least 
24 hours without mechanical ventilation. Patients not 
requiring OTI or with less than 24 hours mechani-
cal ventilation were included in the IMV < 24 hours 
group. In this study, the ICU length of stay was con-
sidered prolonged when lasting more than seven days. 
The data were described by the mean and standard 
deviation calculations. Prevalence was calculated by 
the Chi-square test or the Fisher’s exact test. The risk 
of death was estimated by odds ratio (crude) calcula-
tion and its respective 95% confidence interval. The 
risk-of-death factors were analyzed by multivariate lo-
gistic regression, using stepwise selection criteria. For 
every statistics a 5% level of significance was consid-
ered. The analyses were conducted with the 9.1 ver-
sion SAS software. 
RESULTS
During the 6-month period, 422 patients were ad-
mitted to the adult ICU of the HC-UNICAMP. Twen-
ty one patients were excluded: one due to transference 
to another service, one for incorrect data, and nine-
teen for incomplete medical chart data. Four hundred 
and one patients were included, of which 239 (56.9%) 
were males and 162 (40.4%) females. The mean age 
was 53.8 ± 18.0 years. Ninety patients (22.4%) were 
under 40 years of age, 155 (38.7%) between 40 and 
60 years, and 156 (38.9%) over 60 years of age.
The mean APACHE II score was 12.0 ± 5.6, me-
dian 11; 206 (51.4%) patients had APACHE II score 
below 11, whereas among 195 (48.6%) this score was 
above 11 (Tables 1 and 2). One hundred and twenty-
five (31.2%) patients stayed longer than 7 days in the 
ICU, with a mean length of ICU stay between 8.2± 
10.8 days, median 4, range 1 to 109. One hundred 
and ninety-one (47.6%) patients were admitted ex-
tubated or remained less than 24 hours under IMV, 
210 (52.4%) remained mechanically ventilated ≥ 24 
hours and 75 (35.7%) were ≥ 7 days under invasive 
mechanical ventilation. The mean IMV days was 9.3 
± 14.3, median 3, range 1 to 98. Among the 210 pa-
Table 1 – Overall sample characteristics 
Characteristics N = 401 %
Gender    
     Male 239 59.6
     Female 162 40.4
Age (years)    
     < 40 90 22.4
     40-60 155 38.7
     > 60 156 38.9
APACHE II    
     Up to 11 206 51.4
     > 11 195 48.6
Invasive mechanical ventilation
    < 24 h 191 47.6
     ≥ 24 h 210 52.4
ICU length of stay
    < 7 days 276 68.8
    ≥ 7 days 125 31.2
APACHE II - Acute Physiology and Chronic Health Evaluation; ICU - 
intensive care unit.
Table 2 – Overall sample characteristics
Variables N Result
Age (years) 401 53.8 ± 18.0
APACHE II 401 12.0 ± 5.6
ICU length of stay (days) 401 8.2 ± 10.8
IMV time (days) 210 9.3 ± 14.3
Tracheostomy time (days) 55 9.4 ± 4.9
APACHE II - Acute Physiology and Chronic Health Evaluation; ICU 
– intensive care unit; IMV – invasive mechanical ventilation. Data ex-
pressed as mean ± standard deviation.
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tients, fifty-five (26.2%) underwent tracheostomy, 
and the mean IMV days before tracheostomy was 9.4 
± 4.9. Thirty-two (15.2%) patients were reintubated 
(Tables 1, 2 and 3). The main ReOTI causes were: 
post-extubation upper airways obstruction (15.6%); 
hypoxemia (SaO2 < 90%, or PaO2 < 60 mmHg with 
FiO2 > 50%) (18.8%); increased respiratory load (in-
tercostal, diaphragm or furcula sampling, use of ac-
cessory muscles or paradoxical breathing), reduced 
consciousness level (15.6%), reoperation (3.1%) and 
others (6.3%) (Table 4).
The entire ICU population mortality rate was 
13.46%. No significant gender influence on mortality 
was identified. However, in the multivariate analysis 
patients between 40 and 60 years old had increased 
the risk of death (OR 3.86; 95%CI 1.39-10.70). 
APACHE II score > 11 (OR 5.01; 95%CI 2.50-
10.05; P<0.0001), ReOTI (OR 8.71; 95%CI 4.03-
18.81; P<0.0001), ≥ 7 days IMV (OR 3.82; 95%CI 
1.99-7.36; P<0.0001) and tracheostomy (OR 5.09; 
95%IC 2.66-9.77; P<0.0001) were also pointed out 
as mortality risk factors (Table 5).
Regarding prolonged ICU stay no significant dif-
Table 3 – Above 24 hours invasive mechanical ventilation 
sample characteristics
 Characteristics N = 210 %
Invasive mechanical ventilation days 
     < 7 days 135 64.3
      ≥ 7 days 75 35.7
Tracheostomy
     No 155 73.8
     Yes 55 26.2
Reintubation    
     No 178 84.8
     Yes 32 15.2
Table 4 – Causes of reintubation 
 Causes N = 32 %
Upper airways obstruction 5 15.6
Hypoxemia 6 18.8
Increased respiratory load 13 40.6
Reduced consciousness level 5 15.6
Reoperation 1 3.1
Others 2 6.3
Table 5 – Analysis of risk factors associated with mortality 
  Discharge Death  
 Variable N = 347 N = 54   Univariate OR Multivariate OR
  N N % p value OR (95%CI) OR (95%CI)
Gender     0.21   NS
     Male 211 28 11.7   1.00
     Female 136 26 16.0   1.44 (0.81 - 2.56)
Age     0.80    
     < 40 79 11 12.2   1.00 1.00
     40 to 60 132 23 14.8   1.25 (0.58 - 2.70) 3.86 (1.39 - 10.70)
     > 60 136 20 12.8   1.06 (0.48 -2.32) 1.81 (0.65 - 5.04)
APACHE II     < 0.0001   NS
     Up to 11 195 11 5.3   1.00
     > 11 152 43 22.1   5.01 (2.50 - 10.05)
ReOTI     < 0.0001    
     No 331 38 10.3   1.00 1.00
     Yes 16 16 50.0   8.71 (4.03 - 18.81) 4.67 (1.74 - 12.56)
IMV time (days)     < 0.0001   NS
      < 7 days 114 21 15.6 1.00
      ≥ 7 days 44 31 41.3 3.82 (1.99 - 7.36)
Tracheostomy < 0.0001 NS
      No 312 35 10.1 1.00
      Yes 35 20 36.4   5.09 (2.66 - 9.77)  
Chi-square test; * Fisher’s exact test; stepwise logistic regression; NS – non-significant; IMV – invasive mechanical ventilation; ReOTI – orotracheal 
reintubation; DInterUTI – ICU length of stay (days); DVMI – days in invasive mechanical ventilation; APACHE II - Acute Physiology and Chronic 
Health Evaluation.
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ference was found for gender. Patients between 40 and 
60 years of age stayed longer in the intensive care unit 
as compared with younger or older patients (OR 0.43; 
95%CI 0.25-0.76; P=0.01) (Table 6).
APACHE II score > 11 (OR 2.75; 95%CI 1.77-
4.27; P<0.0001), ReOTI (OR 27.49; 95%CI 8.19-
92-30; P<0.0001) and/or tracheostomy (OR 29.01; 
95%CI 11.97-70.31; P<0.0001) (Table 6) were sig-
nificantly associated with prolonged ICU time of stay. 
DISCUSSION
We considered as prolonged ICU stay a patient re-
maining in the ICU longer than seven days, however 
we could not identify any literature consensus with 
ranging averages, e.g., 3 days,(2) 7 days,(8,9) 10 days,(10) 
14 days,(5,11) or 30 days.(12,13) It is understood that this 
lack of literature consensus is probably due to most 
of the studies were conducted in mixed populations 
(i.e. both clinical and surgical patients). New studies 
ought to be conducted with better group characteriza-
tion. 
In the unit analyzed, a higher number of men were 
admitted. However, no significant difference regard-
ing both mortality and prolonged stay between the 
genders was identified. Most of the studies confirm 
these data.(2-4,11) Only Fowler et al.(14) found a higher 
mortality rate in women. 
In this study the mean age was 53.8± 18,0 years 
without significant difference identified for the admis-
sion of age groups.  Mortality was proved to be higher 
in the group of patients between 40 and 60 years of 
age. Some studies identified advanced age to be as-
sociated with higher mortality rates, however these 
may have been influenced by other variables as they 
had small samples.(3,15) In a larger population study 
the mortality risk was not found to be associated with 
age.(10) Perhaps the effect of age on prognosis may be 
associated with other issues, such as disease severity 
and previous functional status.(3,16) 
Prognosis indicators are being increasingly used for 
ICU quality assessment, comparison to other ICUs, 
or patient’s randomization for clinical trial proto-
cols. The APACHE II severity score assesses variables 
such as clinical, physiological and laboratory param-
eters as well as chronic disease and age, within the 
first 24 hours from admission.(17) Higher APACHE II 
scores are related to higher risks of death. The mean 
Table 6 – Analysis of risk factors for prolonged intensive care unit stay 
  < 7 days ≥ 7 days
Variable N = 276 N = 125 Univariate OR Multivariate OR
  N N % p value OR (95%CI) OR (95%CI)
Gender   0.9123   NS
     Male 165 74 31.0   1.00
     Female 111 51 31.5   1.02 (0.67 - 1.58)
Age (years)   0.0109   NS
     < 40 53 37 41.1   1.00
     40 to 60 119 36 23.2   0.43 (0.25 - 0.76)
     > 60 104 52 33.3   0.72 (0.42 - 1.22)
APACHE II   <0.0001   NS
     Up to 11 163 43 20.9   1.00
     > 11 113 82 42.1   2.75 (1.77 - 4.27)
ReOTI   <0.0001*    
     No 273 96 26.0   1.00 1.00
     Yes 3 29 90.6   27.49 (8.19 - 92.30) 13.15 (3.36 - 51.43)
IMV time (days)   <0.0001*   NS
     < 7 days 103 32 23.7 1.00
     ≥ 7 days 2 73 97.3 117.48 (27.29 - 505.74)
Tracheostomy <0.0001
     No 270 76 22.0 1.00 1.00
     Yes 6 49 89.1   29.01 (11.97 - 70.31) 13.27 (4.89 - 35.99)
Chi-square test; *Fisher’s exact test; stepwise logistic regression; NS – non-significant; IMV – invasive mechanical ventilation; ReOTI – 
orotracheal reintubation; APACHE II - Acute Physiology and Chronic Health Evaluation.
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APACHE II score, in literature, ranges from 12.8 to 
24.9,(5,11,12,18) and in this study the APACHE II score 
averaged 12.0. Patients with APACHE II score above 
11 had increased mortality and longer ICU stays, 
confirming the findings by Laupland et al.(5) It is un-
derstood that this prognostic instrument should be 
deemed just one additional tool for a doctor facing 
difficult decisions regarding therapeutic limitation or 
ICU beds distribution. 
IMV is another factor considered to be associated 
with mortality risk and ICU length of stay.(11,13,18-20) 
According to the National Association for Medical 
Direction of Respiratory Care (NAMDRC) 2004 con-
sensus,(21) the recent increase of number of patients 
undergoing prolonged time of mechanical ventilation 
is due to improved ICU care and technological evo-
lution. An international prospective study reported 
that patients who required IMV remained in average 
7 days under respiratory support, with 13 days ICU 
length of stay.(22) This study  displayed that that 50% 
of patients who were not extubated within the first 24 
hours stayed longer than 7 days in the ICU. Similar 
results were reported by Higgins et al.(23), in which 
mechanical ventilation was associated with infection 
and long ICU stay. IMV is then believed to indicate 
worse prognosis and that the longer it is maintained, 
the longer a patient’s ICU stay will be.
The literature has stated that the use of protocols 
for IMV weaning managed by a multi-professional 
team, may significantly reduce IMV duration and 
consequently reduce the ICU length of stay.(24,25) The 
ICU should have an appropriately sized and trained 
multi-professional team, daily visit structured check-
list focusing on the patient’s eligibility for mechanical 
ventilation weaning.(26) Nisim et al.(27) in a recent study 
found that 95.3% of pre-extubation protocol patients 
were successfully extubated, while those not included 
in the protocol had increased ICU length of stay. 
This study identified worse prognosis and pro-
longed ICU stay time for unsuccessful extubation pa-
tients. Caroleo et al.(28)  observed that among people 
whose ages are  over 70 years, pre-extubation mechan-
ical ventilation time, anemia (hemoglobin (Hb) < 10 
g/dL and hematocrit (Ht) > 30%), disease severity by 
the time of extubation, use of continued infusion se-
dation and patient’s transportation  out of the ICU 
may have the risk of reintubation increased. In a study 
by Esteban et al.(22) patients undergoing unplanned or 
accidental extubation had worse prognosis. Studies 
have described increased mortality and ICU length of 
stay up to 9 days for reintubated patients.(29,30) How-
ever, Ferrer,(31) in a systematic literature review, states 
that non-invasive mechanical ventilation immediately 
after extubation may be effective for post-extubation 
respiratory failure prevention in  complication-risk 
patients specially those with chronic respiratory disor-
ders or hypercapnic respiratory failure. Although our 
study has collected the causes leading to reintubation, 
our data are not sufficient to describe the variables 
which may have influenced the reintubation rates. 
New studies ought to be supported .
Patients requiring prolonged IMV, whose clinical 
status does not allow weaning, may undergo upper air-
ways tracheostomy for protection. This type of cannu-
lation may facilitate mechanical ventilation weaning 
as it reduces dead spaces and upper airways resistance, 
improves pulmonary secretions removal and reduces 
sedation requirements; nevertheless controlled stud-
ies on this subject are scarce.(32)  Rumbak et al.(33) is 
one of the few randomized clinical trials in the litera-
ture on tracheostomy, showing mortality, incidence of 
pneumonia, ICU length of stay, and mechanical ven-
tilation time benefits in early tracheostomy patients 
(within the first 48 hours under OTI) versus conven-
tional tracheostomy (after 14 days OTI). However, 
this study has shown that tracheostomyzed patients 
have displayed increased mortality in agreement with 
the findings by Colpan et al.(18) and longer ICU stay 
time; nonetheless, these data should be reassessed tak-
ing into consideration the tracheostomy time (early/
late), mechanical ventilation days and other variables.
CONCLUSION
It is possible to conclude that in this study 
APACHE II > 11, tracheostomy and reintubation 
were associated with increased mortality rate and pro-
longed ICU stay.
RESUMO
Objetivo: A unidade de terapia intensiva é sinônimo de 
gravidade e apresenta taxa de mortalidade entre 5,4% e 33%. 
Com o aperfeiçoamento de novas tecnologias, o paciente pode 
ser mantido por longo período nessa unidade, ocasionando altos 
custos financeiros, morais e psicológicos para todos os envolvi-
dos. O objetivo do presente estudo foi avaliar os fatores associa-
dos à maior mortalidade e tempo de internação prolongado em 
uma unidade de terapia intensiva adulto. 
Métodos: Participaram deste estudo todos os pacientes ad-
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mitidos consecutivamente na unidade de terapia intensiva de 
adultos, clínica/cirúrgica do Hospital das Clínicas da Univer-
sidade Estadual de Campinas, no período de seis meses. Foram 
coletados dados como: sexo, idade, diagnóstico, antecedentes 
pessoais, APACHE II, dias de ventilação mecânica invasiva, 
reintubação orotraqueal, traqueostomia, dias de internação na 
unidade de terapia intensiva, alta ou óbito na unidade de terapia 
intensiva. 
Resultados: Foram incluídos no estudo 401 pacientes, 
sendo 59,6% homens e 40,4% mulheres, com idade média de 
53,8±18,0 anos. A média de internação na unidade de terapia 
intensiva foi de 8,2±10,8 dias, com taxa de mortalidade de 
13,46%. Dados significativos para mortalidade e tempo de inter-
nação prolongado em unidade de terapia intensiva (p<0,0001), 
foram: APACHE II >11, traqueostomia e reintubação. 
Conclusão: APACHE >11, traqueostomia e reintubação 
estiveram associados, neste estudo, à maior taxa de mortalida-
de e tempo de permanência prolongado em unidade de terapia 
intensiva.
Descritores: Unidade de terapia intensiva; Mortalidade; 
Tempo de internação; Fatores de risco
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